The firm assists one of the world's largest clinical laboratory network's in pre-acquisition and pre-licensing due diligence relating to technology assets, including genetic markers, laboratory technologies and methodologies, microfluidics and related intellectual property. The firm also assists in the preparation and review of acquisition and licensing documents resulting from the due diligence.

Experience Center

Match our Experience to Your Needs

Experience Highlights

Formation of venture capital and investment fund for venture capital company
Represented a venture capital company in connection with the formation and securities offering of a real estate investment fund. more
Corporate governance investigation for a Midwest-based REIT
Represented a Midwest-based REIT in a corporate governance investigation. The firm reported to an audit committee of the NYSE-listed issuer regarding more
Trademark and unfair competition matters for Pfizer Inc.
Represents Pfizer Inc., one of the world's largest pharmaceutical companies, in trademark and unfair competition matters, including litigation before more
Public offering for Superior Essex Inc.
Represented Superior Essex Inc. in an $86 million secondary public offering of common stock. more